Ionis Pharmaceuticals IONS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's total assets?
- Ionis Pharmaceuticals (IONS) reported total assets of $3.45B in Q1 2026.
- How has Ionis Pharmaceuticals's total assets changed year-over-year?
- Ionis Pharmaceuticals's total assets increased by 22.6% year-over-year, from $2.81B to $3.45B.
- What is the long-term trend for Ionis Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's total assets has grown at a 8.1% compound annual growth rate (CAGR), from $2.39B to $3.52B.
- What does total assets mean?
- The sum of everything the company owns, including cash, property, and investments.
- How do you interpret total assets?
- Growth in total assets generally indicates company expansion, while a decline may suggest asset liquidation or impairment.
- How does total assets compare across companies?
- Used to compare the overall scale and capital intensity of companies within the same sector.